Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Illinois at Chicago
H. Lee Moffitt Cancer Center and Research Institute
University of Chicago